Event Reports

On the 17th of November, the Pharmaceutical and Medical Technology Working Group held its first offline meeting since the pandemic, at Novartis Indonesia Office. The meeting was led by the Head of the Working Group, Hanum Yahya (Country Head of Public Affairs, Communications and Engagement). The meeting discussed several agendas including updates of the B20 and G20 on accessible healthcare, results of the joint chambers meeting with APACMed, policy updates on the pharmaceutical and medical technology sector, and upcoming activities for the working group. The meeting aims to strengthen advocacy efforts to strengthen resilience in the sector.

We would like to congratulate the new Deputy of the Pharmaceutical & Medical Technology Working Group, Mr. Andri Kusandri (Market Access and Government Affairs Director at Merck). We would also like to thank the participants who attended face to face and hybrid for actively contributed to the meeting.

On 16 November, EuroCham warmly welcomed delegates from PT Anugerah Pharmindo Lestari Lestari, a member of Zuellig Pharma, and also proud member of EuroCham Indonesia (The European Business Chamber of Commerce in Indonesia). The meeting provided a brief introduction to EuroCham and our advocacy work, and had an in-depth discussion of the current policy landscape in Indonesia and the future of the investment and business climate in Indonesia.

The meeting was attended by Raymund Azurin, Senior Vice President of Corporate Affairs at Zuellig Pharma Asia Pacific, Aulia Citta Arieni, Market Access and Regulatory Affairs Manager, and Helen Marlina, Head Of Corporate Communications, Brand, and Sustainability.